A meticulous systematic review has cast new light on the battle against Equine Herpes Virus type 1 (EHV-1), a formidable adversary responsible for upper respiratory disease, neurological disorders, abortions, and neonatal fatalities in horses. The critical question at the heart of this research: Can pharmacological therapy effectively reduce the incidence or severity of EHV-1 in domesticated horses?